Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ALC✓SelectedUSD · ALCGSK vs ALC performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs ALC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
ALC return
-8.9%
Excess return
+55.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioALCExcessAlpha
1D-0.1%-0.6%+0.6%+0.1%
7D-1.3%-2.0%+0.7%-0.7%
30D+2.7%+11.3%-8.5%-0.4%
3M+2.7%-0.8%+3.5%+2.8%
6M+3.3%+15.7%-12.4%-1.2%
YTD+6.5%-6.1%+12.6%+7.6%
1Y+10.7%-4.7%+15.4%+11.3%
3Y+64.4%+7.1%+57.3%+59.5%
5Y+46.7%-9.6%+56.3%+46.7%
All+46.7%-8.9%+55.6%+46.7%

Cumulative growth

Daily Returns

Daily percentage return beside ALC.

Daily Out/Under-Performance

Portfolio return minus ALC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ALC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded ALC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling